第四屆年度幼兒發展醫學研討會，法國巴黎

澤維爾·索拉尼奇醫師，哲學博士
醫院大道
法國巴黎
2016 年 4 月 1 日

2016 年巴黎醫學研討會團體照

研討會摘要

Erdheim-Chester Disease Global Alliance 很榮幸提供以下摘要，內容為本年度第 4 屆年度國際 ECD 醫學研討會的演講重點。本次研討會於 2016 年 9 月 15 日在法國巴黎的 Hôpital Pitié-Salpêtrière 舉行。此次會議讓醫療專業人員得以就 ECD 研究進行合作、分享醫學發現，並討論病患照護。感謝本年度共同主辦人 Julien Haroche 教授（醫學博士、博士）；感謝所有在座談討論中分享資料與專業的講者；感謝所有有興趣進一步了解 ECD 的與會者；也感謝所有參與規劃並促成本活動成功的夥伴。特別感謝為社群撰寫本摘要的志工，以及所有因故未能出席的專業人士。

含研討會議程的計畫

介紹

2016 年會議中發表了以下簡報。請造訪 ECD Global Alliance YouTube 頻道 觀看所有已發佈的 ECD 相關 影片。

PresenterPresentation SlidesVideos
Corrado Campochiaro, MDManagement of ECD Symptoms and Side Effects of TreatmentsManagement of ECD Symptoms and Side Effects of Treatments
Giulio Cavalli, MDAdult Onset (Infratentorial) Leukoencephalopathy as Presenting Manifestation of Erdheim-Chester DiseaseAdult Onset (Infratentorial) Leukoencephalopathy as Presenting Manifestation of Erdheim-Chester Disease
Carine Courtillot, MDEndocrine manifestations in Erdheim-Chester diseaseEndocrine manifestations in Erdheim-Chester disease
Benjamin Durham, MDInsights into the Cell-of-Origin of the Histiocytoses Using Patient-Derived Xenograft Murine ModelsInsights into the Cell-of-Origin of the Histiocytoses Using Patient-Derived Xenograft Murine Models
Marina Ferrarini, MDTailoring Treatment for Erdheim-Chester Disease: Focus on ECDTailoring Treatment for Erdheim-Chester Disease: Focus on ECD
Ronald Go, MDEfficacy of Cladribine (2-CdA) in the Treatment of Erdheim-Chester Disease (ECD)Efficacy of Cladribine (2-CdA) in the Treatment of Erdheim-Chester Disease (ECD)
Filip Janku, MD, PhDEncouraging activity of MEK inhibitor trametinib in patients with Erdheim-Chester disease irrespective of BRAF mutation statusClinical Molecular Profiling to Detect Targetable Alterations in Archival Tumor Tissue and Cell-free DNA from Patients with Erdheim-Chester DiseaseEncouraging activity of MEK inhibitor trametinib in patients with Erdheim-Chester disease irrespective of BRAF mutation statusClinical Molecular Profiling to Detect Targetable Alterations in Archival Tumor Tissue and Cell-free DNA from Patients with Erdheim-Chester Disease
Javier Martin, MD, PhDFuture Genetic Studies in Erdheim-Chester disease – GWAS StudyFuture Genetic Studies in Erdheim-Chester disease – GWAS Study
Kenneth McClain, MD, PhDElevated CSF Osteopontin and Circulating Cells with BRAF Mutations in Patients with Langerhans Cell Histiocytosis-Associated Neurodegeneration -A Model for ECD?Elevated CSF Osteopontin and Circulating Cells with BRAF Mutations in Patients with Langerhans Cell Histiocytosis-Associated Neurodegeneration -A Model for ECD?
Augusto Vaglio, MD, PhDMRI evidence of cardiac involvement in Erdheim-Chester diseaseMRI evidence of cardiac involvement in Erdheim-Chester disease